Zobrazeno 1 - 10
of 30
pro vyhledávání: '"F. Caro-Sampara"'
Autor:
Dan Lipsker, Yves Piémont, P. Attali, Yves Hansmann, F. Grunenberger, Benoît Jaulhac, Jean Sibilia, F. X. Limbach, M. Kubina, F. Caro-Sampara, M. Frey, C. Clerc, C. Tranchant
Publikováno v:
Scopus-Elsevier
Since very little is known about the clinical expression of Lyme borreliosis in Western Europe, a 3-year prospective study was conducted that included all patients seen for suspected Lyme borreliosis at the Strasbourg University Hospital in northeast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c312f84b8bcecdd682f8352196a06769
https://doi.org/10.1007/s100960100476
https://doi.org/10.1007/s100960100476
Autor:
François Jehl, Henri Monteil, F. Caro-Sampara, J. F. Westphal, M Adloff, Brogard Jm, Blickle Jf
Publikováno v:
Antimicrobial Agents and Chemotherapy. 41:1636-1640
Piperacillin-tazobactam concentrations in serum and bile were measured intraoperatively in 10 patients undergoing cholecystectomy (group 1) and 5 cholecystectomized patients provided with external bile duct drainage (group 2). Each patient received a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a00e71edf58a51f8e0779cf880304e
https://doi.org/10.1128/aac.41.8.1636
https://doi.org/10.1128/aac.41.8.1636
Publikováno v:
Pathologie-biologie. 47(8)
The objective of this study was to determine the extent of biliary excretion of tazocillin, a combination of piperacillin and tazobactam administered as an intravenous infusion in a dose of 4 g of piperacillin and 0.5 g of tazobactam. In 10 patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2bee7f950bbd66641b26d2b478d6ff41
https://pubmed.ncbi.nlm.nih.gov/10573704
https://pubmed.ncbi.nlm.nih.gov/10573704
Publikováno v:
Drugs under experimental and clinical research. 20(6)
Biliary elimination and hepatic disposition of tazocillin, an association of a highly bile-excreted ureido-penicillin, piperacillin, with a beta-lactamase inhibitor, tazobactam, have been assessed applying an isolated perfused rabbit liver experiment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba7198e26e18386d4496d0767905eb02
https://pubmed.ncbi.nlm.nih.gov/7758397
https://pubmed.ncbi.nlm.nih.gov/7758397
Publikováno v:
La Revue de medecine interne. 14(10)
The comparison of the results of two insulin assays, a RIA using a polyclonal antibody and a EMIA using two monoclonal antibodies in blood samples collected during an oral glucose load in normal, obese, glucose intolerant and type II diabetic patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b541a04bb16ba97a047a627b54c1b60c
https://pubmed.ncbi.nlm.nih.gov/8009086
https://pubmed.ncbi.nlm.nih.gov/8009086
[Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors]
Publikováno v:
La Revue de medecine interne. 13(1)
The evidence of sorbitol excess in the crystalline lens of alloxan-diabetic rats has led to anticipate the role of the enzyme aldose-reductase in the pathogenesis of the diabetic cataract. In addition, a number of experimental works have more recentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b65d91cbf32728b30dd08de8b519f306
https://pubmed.ncbi.nlm.nih.gov/1410879
https://pubmed.ncbi.nlm.nih.gov/1410879
Publikováno v:
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 1(6)
Amyloidosis of the bladder associated with systemic amyloidosis secondary to rheumatoid arthritis is a rare disease. Due to the absence of routine screening, its incidence appears to be understimated and only 11 cases, all symptomatic, have been repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf8b28b57fa0fff573b6ccbae93d18be
https://pubmed.ncbi.nlm.nih.gov/1844738
https://pubmed.ncbi.nlm.nih.gov/1844738
Publikováno v:
La Revue de Médecine Interne. 14:993
The comparison of the results of two insulin assays, a RIA using a polyclonal antibody and a EMIA using two monoclonal antibodies in blood samples collected during an oral glucose load in normal, obese, glucose intolerant and type II diabetic patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02c149188f4d428524b7e1cc7ada26cb
https://doi.org/10.1016/s0248-8663(05)80111-0
https://doi.org/10.1016/s0248-8663(05)80111-0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.